1. Matthews J.B., Ramos E. and Bluestone J.A. (2003) Clinical trials of transplant tolerance: slow but steady progress. Am J Transplant 3, 794–803.
2. Bouma G.J., Schanz U., Oudshoorn M., van der Meer-Prins P.M., Roelen D.L., van Rood J.J. and Claas F.H. (1996) A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies. Bone Marrow Transplant
17, 19–23.
3. van Besouw N.M., Zuijderwijk J.M., de Kuiper P., Ijzermans J.N., Weimar W. and van der Mast B.J. (2005) The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. Transplantation
79, 1062–1066.
4. van der Mast B.J., van Besouw N.M., de Kuiper P., Vaessen L.M., Gregoor P.J., Ijzermans J.N., van Gelder T., Claas F.H. and Weimar W. (2001) Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation
72, 873–880.
5. Hornick P.I., Brookes P.A., Mason P.D., Taylor K.M., Yacoub M.H., Rose M.L., Batchelor R. and Lechler R.I. (1997) Optimizing a limiting dilution culture system for quantifying the frequency of interleukin-2-producing alloreactive T helper lymphocytes. Transplantation
64, 472–479.